| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |